Survival benefit of tamoxifen in male breast cancer: prospective cohort analysis

BACKGROUND: Due to the lack of prospective data, current treatment of male breast cancer (MBC) is based on information obtained from retrospective analysis or by extrapolation from studies on female patients. In this prospectively enrolled cohort study, we retrospectively examined the survival effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Eggemann, Holm, Brucker, Cosima, Schrauder, Michael, Thill, Marc, Flock, Felix, Reinisch, Mattea, Costa, Serban-Dan, Ignatov, Atanas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341811/
https://www.ncbi.nlm.nih.gov/pubmed/32367072
http://dx.doi.org/10.1038/s41416-020-0857-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341811/
https://www.ncbi.nlm.nih.gov/pubmed/32367072
http://dx.doi.org/10.1038/s41416-020-0857-z

Ejemplares similares